Walvax
Latest round
- Series A
Last raised
- Mar 2008
Total raised
- $5.1M
Investors
- 2
About Walvax
Established in 2001 and based in Kunming, China, Walvax operates as a biotechnology company that mainly provides vaccines and blood products. It has subsidiaries in Shanghai, Beijing, and Yuxi. In 2007, the first product, Haemophilus influenzae type b conjugate vaccine, was launched. In November 2010, the company was listed on the Shenzhen Stock Exchange. The company mainly provides human vaccine products. Products include non-EPI vaccines (non-EPI) and immunization vaccines (EPI). Non-EPI includes bivalent human papillomavirus vaccine, pneumococcal polysaccharide conjugate vaccine, and Haemophilus influenzae conjugate vaccine. EPI includes group A and group C meningococcal polysaccharide vaccines and adsorbed acellular diphtheria, pertussis and tetanus combined vaccine. Walvax's products under development include nine-valent cervical cancer vaccine, new crown mRNA vaccine, etc. The products are used to prevent bacteremia pneumonia, meningitis, sepsis, bacteremia and other diseases. The company generates revenue by providing human vaccine products such as non-EPI and EPI.
Who invested in Walvax
2 investors across 1 round
See all investors in Walvax
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 31, 2008
Amount
$5.1M
Investors
Questions about Walvax
Who invested in Walvax?
Walvax has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Walvax raised?
Walvax has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Walvax last raise money?
Walvax's most recent round on record is a Series A, in Mar 2008.
What does Walvax do?
Established in 2001 and based in Kunming, China, Walvax operates as a biotechnology company that mainly provides vaccines and blood products.
Where is Walvax headquartered?
Walvax is headquartered in Kunming, China.
Which VCs invest in companies like Walvax?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Walvax's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Walvax? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.